- Advertisement -

A Ballarat-founded biotech led by former Virtus Health CEO Kate Munnings has successfully completed a $35 million initial public offering (IPO) on the Australian Securities Exchange, as Vitrafy Life Sciences (ASX: VFY) looks to commercialise its cryopreservation technology.
Headquartered in…

